PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

MaxiAids Team Experiences a Meal Without Sight at Long Island Council of the Blind's 'Dinner in the Dark' Event

The management team of MaxiAids Products for Independent living were among guests who experienced a meal without sight at the Long Island Council of the Blind's 5th annual 'Dinner in the Dark'.

MaxiAids Team Experiences a Meal Without Sight at Long Island Council of the Blind's 'Dinner in the Dark' Event
2013-05-08
FARMINGDALE, NY, May 08, 2013 (Press-News.org) This past Monday Elliot Zaretsky, president and founder of MaxiAids Products for Independent Living, along with the company's senior management team participated in the 5th annual Dinner in the Dark event at The Sterling in Bethpage.

According to the event sponsor, the Long Island Council of the Blind (LICB), Dinner in the Dark was created "as a way of showing the community-at-large that eating does not always require that one see the meal on the plate to enjoy its taste."

It's also a great way to raise awareness about how visually impaired people function in their everyday lives.

And this year's event had an extra special meaning for MaxiAids, as Mr. Zaretsky was honored for his lifelong dedication to helping people who are blind or who have low vision live more active, independent lives.

After a brief lesson and some helpful tips on how to efficiently navigate a table and place setting, guests enjoyed a three-course meal, with salad and the main course being eaten without sight. To accomplish this, diners were given sleeping masks and the lights were turned down to ensure they experienced the meal as a blind person does.

This was also an interesting challenge for the servers, who made their way around the tables and served plates of food only by the light of glow sticks.

After dinner, the lights were brought up and as guests were able to look at their plates to see how they had done. Over dessert they had a chance to discuss the experience.

"Re-filling a water glass without spilling it was challenging," said Larry DiBlasi, MaxiAids' executive director of operations. "And it was hard to judge the distance and position of place settings - you worry you're taking someone else's fork or drink."

Some guests dove right in feeling around their plates with a knife and fork, while others used fingers help identify by texture what foods they had and where they were situated on the plate. Others acknowledged the difficulty accurately counting change at the cash bar.

One participant perceived heightened senses, feeling they were more aware of sounds and conversations around them, and they even thought food flavors seemed more intense.

"It was definitely a valuable, interesting and educational experience," concluded Mr. DiBlasi. "I'm sure we'll draw upon it frequently as we are developing and designing new products to assist the blind and those with low vision."

MaxiAids is a world-leading provider of products for independent living, supplying an extensive range of items designed to improve the lives of seniors, as well as the blind, low vision, deaf, hard of hearing, diabetic and those with mobility challenges and other special needs. For more information, visit www.MaxiAids.com or call 1-800-522-6294.

[Attachments] See images for this press release:
MaxiAids Team Experiences a Meal Without Sight at Long Island Council of the Blind's 'Dinner in the Dark' Event MaxiAids Team Experiences a Meal Without Sight at Long Island Council of the Blind's 'Dinner in the Dark' Event 2

ELSE PRESS RELEASES FROM THIS DATE:

Repertorio Espanol Announces the World Premiere of Vincent Toro's "21," Winning Play of the 2011 'MetLife Nuestras Voces' National Latino Playwriting Competition

Repertorio Espanol Announces the World Premiere of Vincent Toros "21," Winning Play of the 2011 MetLife Nuestras Voces National Latino Playwriting Competition
2013-05-08
"21" is a comedy about modern family dynamics. A rambunctious Puerto Rican family takes their socially-conscious 21-year-old college graduate to a casino in upstate New York for a celebration. His eccentric parents are hoping this trip will help unify the whole family, unaware that their son is about to drop a bombshell on them. The cast includes Dalia Davi, Abdel Gonzalez, Sandor Juan and Frank Rodriguez. Tickets for "21" start at $27 and may be reserved online at www.repertorio.org or by phone, 1-212-225-9999. "21" is sponsored by MetLife ...

Bruegger's Bagels' Summer Menu Line-Up is Hot, Cool and Sweet

Brueggers Bagels Summer Menu Line-Up is Hot, Cool and Sweet
2013-05-08
Today, Bruegger's Bagels, known for its authentic, New York-style bagels baked fresh in each of its bakeries, introduces a new summer menu unlike any others before with new flavors that are at once bold, spicy, sweet and savory. Executive Chef Philip Smith added completely new flavors and ingredients to the menu this season, reflecting the bagel bakery's commitment to menu items that are flavorful and on trend while staying true to what keeps guests coming back every day. The innovative menu items - available today in all 300-plus bagel bakeries - include: - ...

Canadian Board Diversity Council (CBDC) Chooses InfoTech Solutions for Business for the Diversity 50 2013 Application Process Project

2013-05-08
InfoTech, a leading software house and system solutions company, has completed and delivered CBDC with a customized white labeled version of the Diverse Director Data Source system (also known as 3D) to support CBDC's Diversity 50 2013 Application process. The Diversity 50 is a brand new resource for directors and search firms. It is Canada's first-ever database of qualified diverse men and women from across Canada with strong competencies that align with the requirements of many Canadian boards (www.boarddiversity.ca/diversity-50). The customized solution also includes ...

New class of drug targets skin cancer

2013-05-07
7 May, 2013 -- Sydney, Australia: A new class of drug targeting skin cancer's genetic material has been successfully tested in humans for the first time, opening the way to new treatments for a range of conditions from skin cancers to eye diseases. The research involves the drug Dz13, a targeted molecular therapy, which was developed at the University of New South Wales (UNSW) and has now been found to be safe in a clinical trial of patients with the common skin cancer, basal-cell carcinoma. "This is the first report of a drug of this type to be used in humans," ...

New perspective needed for role of major Alzheimer's gene

2013-05-07
Scientists' picture of how a gene strongly linked to Alzheimer's disease harms the brain may have to be revised, researchers at Washington University School of Medicine in St. Louis have found. People with harmful forms of the APOE gene have up to 12 times the risk of developing Alzheimer's disease compared with those who have other variations of the gene. Many researchers believe that the memory loss and cognitive problems of Alzheimer's result from the buildup over many years of brain amyloid plaques. The plaques are made mostly of a sticky substance called amyloid ...

A giant leap to commercialization of polymer solar cell

2013-05-07
A polymer solar cell is a type of thin film solar cells made with polymers that produce electricity from sunlight by the photovoltaic effect. Most current commercial solar cells are made from a highly purified silicon crystal. The high cost of these silicon solar cells and their complex production process has generated interest in developing alternative photovoltaic technologies. Compared to silicon-based devices, PSCs are lightweight (which is important for small autonomous sensors), solution processability (potentially disposable), inexpensive to fabricate (sometimes ...

New insights into Ebola infection pave the way for much-needed therapies

2013-05-07
The Ebola virus is among the deadliest viruses on the planet, killing up to 90% of those infected, and there are no approved vaccines or effective therapies. A study published by Cell Press on May 7th in the Biophysical Journal reveals how the most abundant protein making up the Ebola virus—viral protein 40 (VP40)—allows the virus to leave host cells and spread infection to other cells throughout the human body. The findings could lay the foundation for the development of new drugs and strategies for fighting Ebola infection. "Little research is available on how the ...

Protecting the heart health of diabetic patients

2013-05-07
Diabetics have an increased risk of developing coronary artery disease and plaque build-up in their arteries, even if they receive cholesterol-lowering therapies. New research published in the May 7th issue of the Cell Press journal Cell Metabolism reveals that high blood sugar levels also boost the production of inflammatory cells, which contribute to plaque build-up in blood vessels. The researchers identify the cause of this increased production in inflammatory cells and find that blocking this new pathway could help safeguard the heart health of diabetic patients. "We ...

Biomechanical performances of old-fashioned leather and modern football helmets

2013-05-07
Charlottesville, VA (May 7, 2013). Researchers at the Center for Injury Biomechanics at Virginia Tech in Blacksburg, Virginia compared the relative safety afforded by two 1930-vintage leather football helmets and 10 modern football helmets during impacts to players' heads. These researchers found that all 10 modern helmets provided significantly more protection than leather helmets used in the first half of the twentieth century, and demonstrated that differences also exist between modern helmets. Details on their methods and findings are found in "Biomechanical performance ...

Type 1 diabetes and heart disease linked by inflammatory protein

2013-05-07
NEW YORK, NY (May 7, 2013) — Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks an inflammatory process that fuels the buildup of artery-clogging plaque. The findings, made in mice and confirmed with human data, suggest new therapeutic targets for reducing heart disease in people with type 1 diabetes. Led by Columbia University Medical Center (CUMC) researchers in collaboration with investigators at New ...

LAST 30 PRESS RELEASES:

Breaking free from dependence on rare resources! A domestic high-performance permanent magnet emerges!

Symptoms of long-COVID can last up to two years after infection with COVID-19

Violence is forcing women in Northern Ireland into homelessness, finds new report

Latin American intensivists denounce economic and cultural inequities in the global scientific publishing system

Older adults might be more resistant to bird flu infections than children, Penn research finds

Dramatic increase in research funding needed to counter productivity slowdown in farming

How chemistry and force etch mysterious spiral patterns on solid surfaces

Unraveling the mysteries of polycystic kidney disease

Mother’s high-fat diet can cause liver stress in fetus, study shows

Weighing in on a Mars water debate

Researchers ‘seq’ and find a way to make pig retinal cells to advance eye treatments

Re-purposed FDA-approved drug could help treat high-grade glioma

Understanding gamma rays in our universe through StarBurst

Study highlights noninvasive hearing aid 

NASA taps UTA to shape future of autonomous aviation

Mutations disrupt touch-based learning, study finds

Misha lived in zoos, but the elephant’s tooth enamel helps reconstruct wildlife migrations

Eat better, breathe easier? Research points to link between diet, lung cancer

Mesozoic mammals had uniform dark fur

Wartime destruction of Kakhovka Dam in Ukraine has long-term environmental consequences

NIH’s flat 15% funding policy is misguided and damaging

AI reveals new insights into the flow of Antarctic ice

Scientists solve decades-long Parkinson’s mystery

Spinning, twisted light could power next-generation electronics

A planetary boundary for geological resources: Limits of regional water availability

Astronomy’s dirty window to space

New study reveals young, active patients who have total knee replacements are unlikely to need revision surgery in their lifetime

Thinking outside the box: Uncovering a novel approach to brainwave monitoring

Combination immunotherapy before surgery may increase survival in people with head and neck cancer

MIT engineers turn skin cells directly into neurons for cell therapy

[Press-News.org] MaxiAids Team Experiences a Meal Without Sight at Long Island Council of the Blind's 'Dinner in the Dark' Event
The management team of MaxiAids Products for Independent living were among guests who experienced a meal without sight at the Long Island Council of the Blind's 5th annual 'Dinner in the Dark'.